Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 28 (6) , 923-929
- https://doi.org/10.1016/s0168-8278(98)80338-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patientsThe Lancet, 1995
- Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.Journal of Clinical Investigation, 1995
- Therapy of chronic hepatitis B with a 6-month course of ribavirinJournal of Hepatology, 1994
- Repeated courses of α-interferon for treatment of chronic hepatitis type BJournal of Hepatology, 1993
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Pilot study of ribavirin and interferon-β for chronic hepatitis BHepatology, 1993
- Interferon-α and zidovudine combination therapy for chronic hepatitis B: Results of a randomized, placebo-controlled trialHepatology, 1993
- Failure of acyclovir to enhance the antiviral effect of α lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis BJournal of Hepatology, 1992